Related Experiment Video
Updated: Jul 31, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis
Shuihua Huang1, Shengxin Zhang2, Lin Yuan3
1Department of Infection, Xiamen Children's Hospital, Xiamen Branch of Fudan University Pediatric Hospital, Xiamen, Fujian, China.
Insights
Severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis presents with prolonged fever and cough. Risk factors include immune disorders and prior treatments, with potentially poor long-term outcomes.
Area of Science:
- Pediatric Infectious Diseases
- Pulmonology
- Mycology
Background:
- Severe pediatric adenoviral pneumonia is a significant respiratory illness in children.
- Invasive pulmonary aspergillosis (IPA) is a serious fungal infection that can complicate viral pneumonias.
- Co-infection of adenoviral pneumonia with IPA poses unique clinical challenges.
Purpose of the Study:
- To analyze the clinical characteristics of severe pediatric adenoviral pneumonia.
- To investigate the concurrent invasive pulmonary aspergillosis in these cases.
- To identify risk factors and outcomes associated with this dual diagnosis.
Main Methods:
- Retrospective analysis of clinical data from five pediatric patients.
- Inclusion criteria: severe adenoviral pneumonia with confirmed invasive pulmonary aspergillosis.
- Data collected: clinical presentation, imaging, microbiological findings, treatment, and outcomes.
Main Results:
- Five children (1 boy, 4 girls) aged 8 months to 2 years presented with prolonged fever (11-35 days) and cough.
- Pulmonary imaging showed opacification, effusion, emphysema, and cavities. Adenovirus and Aspergillus were detected in respiratory samples.
- Bronchoscopy revealed mucosal damage. Treatment involved broad-spectrum antimicrobials, antifungals (voriconazole), and supportive care. Four patients were discharged; long-term follow-up indicated complications like obliterative bronchiolitis and bronchiectasis.
Conclusions:
- Immune dysfunction and prior treatments (antibiotics, steroids) for adenovirus infection are risk factors for secondary IPA in children.
- Diagnosis requires specific evaluation, including bronchoscopy and alveolar lavage fluid culture, due to non-specific symptoms.
- The long-term prognosis for severe pediatric adenoviral pneumonia with IPA is potentially poor, highlighting the need for early detection and management.
Background:
This study aimed to analyze the clinical characteristics of severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis.
Methods:
We retrospectively analyzed the clinical data of five children clinically diagnosed with severe adenoviral pneumonia combined with invasive pulmonary aspergillosis at Xiamen Children's Hospital.
Results:
These five children included one boy and four girls, with ages of onset ranging from 8 months and 15 days to 2 years and 2 months. All of them had fever with a mean duration of 11-35 days and cough. Pulmonary imaging was performed, which revealed solid pulmonary opacification in all five children, pleural effusion in two children, and emphysema and multiple small cavity formations in one child. Multiple microbiological tests were performed on the 5 children, and adenovirus was positive in the alveolar lavage fluid for the first time, and aspergillus culture was positive in the second test. On tracheoscopy, the bronchial mucosa was seen to be congested and edematous or pale and eroded; white moss-like material was seen adhering to the tracheal wall or even blocking the airway. The five children were treated with a combination of two or more broad-spectrum antimicrobials, glucocorticoids, and gamma globulins and underwent bronchoscopy. Voriconazole was added in the treatment regimen after the diagnosis of aspergillosis (28-34 days of treatment). Four of the children were discharged in good condition with a mean total length of hospital stay of 17-47 days. The other child leave against medical advice. Follow-up 3-5 months after discharge showed that one child had been cured; two children had developed obliterative bronchiolitis; one child had developed bronchiectasis; and the remaining child who had been discharged spontaneously was not contactable via telephone.
Conclusions:
Immune disorders and antibiotic and steroid treatments for adenovirus infection are high-risk factors for secondary invasive pulmonary aspergillosis in children. Prolonged fever and cough are the main manifestations, but which lack specificity, and bronchoscopic mucosal-specific injury evaluation and alveolar lavage fluid culture are helpful in the diagnosis of aspergillosis. The long-term prognosis of severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis maybe poor.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

